Clinical Trial Details
EORTC-30869
Back to Clinical Trials Database
Phase II - III prospective randomized study to assess the effect of epirubicin in multiple bladder cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Oct-1987 Date Step1 close: 15-Sep-1989 Date Step2 close: 15-Jan-1990 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 254 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
